Medical device and technologies product provider C.R. Bard (NYSE:BCR) has posted steady, albeit modest growth trends over the last decade or so. Its founding goes back more than a century and provides sales and profit stability with a certain amount of downside protection. However, the richer valuation could handicap future upside potential.

Investopedia Broker Guides: Enhance your trading with the tools from today's top online brokers.

First Quarter Recap
Sales improved 4% to $730 million. Sales in the United States accounted for 68% of the top line and improved a modest but respectable 2%. International sales made up the rest and grew a healthy 10%, with currency fluctuations dragging down the reported total by a single percentage point. Bard also breaks its sales up by four primary operating segments. Oncology (catheters, feeding devices) was the strongest performer and reported 7% growth to account for 27.2% of total sales. Vascular (heart products such as stents and grafts), the largest segment at 28.7% of the quarterly total, reported a 5% growth. Urology (catheters and stents - 25.3% of total sales) logged a modest 3% growth while surgical specialties (soft tissue meshes and patches) were flat at 15.7% of sales. The "other" category accounted for the rest of the top line and grew 4%.

Pretax income also improved 4% to $191.4 million as cost growth kept pace with the sales expansion. Slightly lower tax expense growth resulted in net income growth of 5.2% to $138.7 million, or $1.60 per diluted share.

SEE: Understanding The Income Statement

Outlook and Valuation
For the year, analysts' project sales growth of almost 5% and total sales just over $3 billion. The consensus earnings projection currently stands at $6.67 which, when taking the current stock price of $98 per share, equates to a forward P/E of 14. This is below Bard's five-year average above 20, which is also the industry average. Rivals include Covidien (NYSE:COV), Becton Dickinson (NYSE:BDX), Boston Scientific (NYSE:BSX) and Teleflex (NYSE:TFX), with only Teleflex smaller in terms of sales over the past year.

The Bottom Line
Over the past decade, Bard has grown both sales and earnings at around 10% annually. Growth has slowed to the high single digits over the past five years on average, but international growth has the potential to boost overall trends as it continues to account for a higher proportion of the total top line.

The stock looks pricey based on the P/E, but is less so when looking at cash flow. Last year, Bard operated approximately $7.26 per share in free cash flow, for a trailing cash flow multiple of 13.5. Overall though, this is still a rich multiple given the modest operational growth. On the flip side, there is ample downside protection as product demand is relatively recession resistant.

SEE: 5 Must-Have Metrics For Value Investors

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Ryan C. Fuhrmann did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Options & Futures

    Use Options to Hedge Against Iron Ore Downslide

    Using iron ore options is a way to take advantage of a current downslide in iron ore prices, whether for producers or traders.
  2. Stock Analysis

    Net Neutrality: Pros and Cons

    The fight over net neutrality has become an amazing spectacle. But at its core, it's yet another skirmish in cable television's war to remain relevant.
  3. Markets

    Why Gluten Free Is Now Big Business

    Is it essential to preserving your health, or just another diet fad? Either way, gluten-free foods have become big business.
  4. Professionals

    Chinese Slowdown Affects Iron Ore Market

    The Chinese economy's ongoing slowdown is having a major impact on iron ore demand.
  5. Personal Finance

    A Day in the Life of an Equity Research Analyst

    What does an equity research analyst do on an everyday basis?
  6. Mutual Funds & ETFs

    ETF Analysis: PowerShares S&P 500 Downside Hedged

    Find out about the PowerShares S&P 500 Downside Hedged ETF, and learn detailed information about characteristics, suitability and recommendations of it.
  7. Mutual Funds & ETFs

    ETF Analysis: ProShares Large Cap Core Plus

    Learn information about the ProShares Large Cap Core Plus ETF, and explore detailed analysis of its characteristics, suitability and recommendations.
  8. Mutual Funds & ETFs

    ETF Analysis: iShares Core Growth Allocation

    Find out about the iShares Core Growth Allocation Fund, and learn detailed information about its characteristics, suitability and recommendations.
  9. Mutual Funds & ETFs

    ETF Analysis: iShares MSCI USA Minimum Volatility

    Learn about the iShares MSCI USA Minimum Volatility exchange-traded fund, which invests in low-volatility equities traded on the U.S. stock market.
  10. Stock Analysis

    Should You Follow Millionaires into This Sector?

    Millionaire investors—and those who follow them—should take another look at the current economic situation before making any more investment decisions.
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  3. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  4. PT (Perseroan Terbatas)

    An acronym for Perseroan Terbatas, which is Limited Liability ...
  5. Ltd. (Limited)

    An abbreviation of "limited," Ltd. is a suffix that ...
  6. BHD (Berhad)

    The suffix Bhd. is an abbreviation of a Malay word "berhad," ...
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>

You May Also Like

Trading Center

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!